Clinical TrialID 7973
A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts
NCT05862441
Cutaneous Warts
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 7973
- Evidence Id
- 7973
- Core Evidence Id
- 7973
- Source Clinical Trial Id
- 7969
- Herb2 Clinical Trial Id
- HBCT007969
- Nct Id
- NCT05862441
- Title
- A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts
- Status
- Completed
- Phase
- Phase 2|Phase 3
- Study Result
- No
- Study Condition
- Cutaneous Warts
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: AV2-SA2|DRUG: SA
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 260
- Outcome Measure
- Efficacy of AV2-SA treatment versus standard SA treatment: cure rate, To assess the efficacy of AV2-SA treatment versus standard SA treatment by comparing cure rates of the index warts between the two treatment groups at 12 weeks after enrollment., 12 weeks after enrollment|Efficacy of AV2-SA treatment versus standard SA treatment: recurrence rate, To assess the efficacy of AV2-SA treatment versus standard SA treatment by comparing recurrence rates of the index warts between the two treatment groups at 6 months after enrollment., 6 months after enrollment
- Sponsor Collaborator
- Universiteit Antwerpen
- Funded By
- OTHER
- Location
- University of Antwerp, Antwerp, 2610, Belgium
- Other Id
- OVW-SA001
- Start Date
- 2018-01-01
- Primary Completion Date
- 2019-12-31
- Completion Date
- 2019-12-31
- First Posted
- 2023-05-17
- Results First Posted
- Last Update Posted
- 2023-05-17
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT05862441
- Title Cn
- Title En
- A Study to Assess the Efficacy of Omnivirol-Salicylic Acid Combination Therapy for Cutaneous Warts With Emphasis on Persistent Warts
- Bilingual Status
- semi_complete